These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 7591992)

  • 1. Glycobiology: 'the function of sugar in the IgG molecule'.
    Dwek RA; Lellouch AC; Wormald MR
    J Anat; 1995 Oct; 187 ( Pt 2)(Pt 2):279-92. PubMed ID: 7591992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
    Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
    J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein.
    Malhotra R; Wormald MR; Rudd PM; Fischer PB; Dwek RA; Sim RB
    Nat Med; 1995 Mar; 1(3):237-43. PubMed ID: 7585040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the murine unglycosylated IgG1 Fc fragment.
    Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
    J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.
    Nimmerjahn F; Anthony RM; Ravetch JV
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8433-7. PubMed ID: 17485663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
    Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
    J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis.
    Martin K; Talukder R; Hay FC; Axford JS
    J Rheumatol; 2001 Jul; 28(7):1531-6. PubMed ID: 11469458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis.
    Bond A; Cooke A; Hay FC
    Eur J Immunol; 1990 Oct; 20(10):2229-33. PubMed ID: 2242757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG.
    Tsuchiya N; Endo T; Matsuta K; Yoshinoya S; Aikawa T; Kosuge E; Takeuchi F; Miyamoto T; Kobata A
    J Rheumatol; 1989 Mar; 16(3):285-90. PubMed ID: 2498512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-specific glycoforms of Fc gamma RIIIa (CD16): differential ligand binding.
    Edberg JC; Kimberly RP
    J Immunol; 1997 Oct; 159(8):3849-57. PubMed ID: 9378972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
    Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
    J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a selectin-like mutant of mannose-binding protein complexed with sialylated and sulfated Lewis(x) oligosaccharides.
    Ng KK; Weis WI
    Biochemistry; 1997 Feb; 36(5):979-88. PubMed ID: 9033386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A stable conformer of IgG, prepared by an acidic influence: study by calorimetry, binding of the C1q complement component, and monospecific anti-IgG].
    Kravchuk ZI; Vlasov AP; Liakhnovich GV; Martsev SP
    Biokhimiia; 1994 Oct; 59(10):1458-77. PubMed ID: 7819387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype and glycoform selection for antibody therapeutics.
    Jefferis R
    Arch Biochem Biophys; 2012 Oct; 526(2):159-66. PubMed ID: 22465822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.